These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9210674)

  • 1. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
    Oakley KL; Morrissey G; Denning DW
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
    Warn PA; Sharp A; Morrissey G; Denning DW
    Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis.
    Verweij PE; Oakley KL; Morrissey J; Morrissey G; Denning DW
    Antimicrob Agents Chemother; 1998 Apr; 42(4):873-8. PubMed ID: 9559799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
    Denning DW; Hall L; Jackson M; Hollis S
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1809-14. PubMed ID: 7486923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA; Morrissey G; Morrissey J; Denning DW
    J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice.
    Tansho S; Abe S; Ishibashi H; Torii S; Otani H; Ono Y; Yamaguchi H
    J Infect Chemother; 2006 Dec; 12(6):355-62. PubMed ID: 17235640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.
    Oakley KL; Moore CB; Denning DW
    Antimicrob Agents Chemother; 1997 May; 41(5):1124-6. PubMed ID: 9145880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
    Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus.
    Dannaoui E; Borel E; Persat F; Monier MF; Piens MA; Network E
    J Med Microbiol; 1999 Dec; 48(12):1087-1093. PubMed ID: 10591162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone.
    Manavathu EK; Dimmock JR; Vashishtha SC; Cutright J; Chandrasekar PH
    J Antimicrob Chemother; 1998 Nov; 42(5):585-90. PubMed ID: 9848441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itraconazole resistance in Aspergillus fumigatus.
    Denning DW; Venkateswarlu K; Oakley KL; Anderson MJ; Manning NJ; Stevens DA; Warnock DW; Kelly SL
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1364-8. PubMed ID: 9174200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
    Snelders E; van der Lee HA; Kuijpers J; Rijs AJ; Varga J; Samson RA; Mellado E; Donders AR; Melchers WJ; Verweij PE
    PLoS Med; 2008 Nov; 5(11):e219. PubMed ID: 18998768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
    Warn PA; Sharp A; Mosquera J; Spickermann J; Schmitt-Hoffmann A; Heep M; Denning DW
    J Antimicrob Chemother; 2006 Dec; 58(6):1198-207. PubMed ID: 17071636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
    Allendoerfer R; Loebenberg D; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
    Abraham OC; Manavathu EK; Cutright JL; Chandrasekar PH
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):7-11. PubMed ID: 9990469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired itraconazole resistance in Aspergillus fumigatus.
    Dannaoui E; Borel E; Monier MF; Piens MA; Picot S; Persat F
    J Antimicrob Chemother; 2001 Mar; 47(3):333-40. PubMed ID: 11222566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Prince RA; Chi J; Kontoyiannis DP
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.
    Connolly P; Wheat J; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):322-8. PubMed ID: 9925526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.
    Denning DW; Radford SA; Oakley KL; Hall L; Johnson EM; Warnock DW
    J Antimicrob Chemother; 1997 Sep; 40(3):401-14. PubMed ID: 9338494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients.
    Negri CE; Gonçalves SS; Sousa ACP; Bergamasco MD; Martino MDV; Queiroz-Telles F; Aquino VR; Castro PTO; Hagen F; Meis JF; Colombo AL
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.